![]() |
Volumn 99, Issue 10, 2007, Pages 1448-1450
|
Effect of Statin Therapy on Survival in Patients With Nonischemic Dilated Cardiomyopathy (from the Beta Blocker Evaluation of Survival Trial [BEST])
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTITHROMBOCYTIC AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
BUCINDOLOL;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
PLACEBO;
ADULT;
ARTICLE;
ATHEROSCLEROTIC PLAQUE;
CHOLESTEROL BLOOD LEVEL;
CIGARETTE SMOKING;
CONGESTIVE CARDIOMYOPATHY;
CONTROLLED STUDY;
DIABETES MELLITUS;
DRUG EFFECT;
DRUG USE;
FEMALE;
GLOMERULUS FILTRATION RATE;
HEART FAILURE;
HEART LEFT VENTRICLE EJECTION FRACTION;
HUMAN;
HYPERTENSION;
MAJOR CLINICAL STUDY;
MALE;
MORTALITY;
NONISCHEMIC DILATED CARDIOMYOPATHY;
PRIORITY JOURNAL;
SCREENING TEST;
SURVIVAL;
SYSTOLIC BLOOD PRESSURE;
ADRENERGIC BETA-ANTAGONISTS;
CARDIOMYOPATHY, DILATED;
FEMALE;
FOLLOW-UP STUDIES;
HEART FAILURE, CONGESTIVE;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
MALE;
MIDDLE AGED;
MULTIVARIATE ANALYSIS;
PROPORTIONAL HAZARDS MODELS;
RESEARCH DESIGN;
RISK FACTORS;
STROKE VOLUME;
SURVIVAL ANALYSIS;
TREATMENT OUTCOME;
|
EID: 34247616042
PISSN: 00029149
EISSN: None
Source Type: Journal
DOI: 10.1016/j.amjcard.2006.12.080 Document Type: Article |
Times cited : (31)
|
References (7)
|